Dr. Max Pharmacy Chain has completed the acquisition of Farmacie Italiane for an undisclosed amount. This corporate acquisition sees Dr. Max taking ownership of Farmacie Italiane, a prominent specialized operator in the Italian retail pharmacy sector, established in November 2018 with investment from F2i. Farmacie Italiane has aimed to be a leading company and a key reference point for citizen health and well-being across Italy.
Farmacie Italiane operates on a distinctive model, conceptualizing its pharmacies as comprehensive spaces for specialized support, advice, and assistance. Beyond providing access to medicines and health products, it functions as a competent territorial entity dedicated to prevention, assistance, and support for chronic care patients, working closely with general practitioners. The company prides itself on offering a wide, convenient, and safe range of wellness products, underpinned by core values of professionalism, trust, respect, and collaboration. It also promotes an inclusive environment and condemns discrimination.
This acquisition represents a significant strategic move for Dr. Max Pharmacy Chain, substantially expanding its footprint and market presence within the Italian pharmaceutical retail landscape. By integrating Farmacie Italiane's innovative, patient-centric approach to community health services and its established territorial network, Dr. Max is poised to enhance and diversify its service offerings. Expected synergies include leveraging Dr. Max's operational scale with Farmacie Italiane's deep local engagement to create a more comprehensive and accessible healthcare retail experience for Italian citizens.
The newly combined entity is set to strengthen its position as a leading provider of health and wellness solutions across Italy. It will leverage the strengths of both organizations to deliver integrated pharmaceutical and advisory services, further developing its role as a vital healthcare-assistance outpost on the territory, always close to the citizen.

